Improving pain management and addiction treatment
Official title: PRomoting Excellence through Pain and Addiction Research Enhancement (PREPARE)
Funded at Washington University · NIH-10935002 · Data updated 2026-11-12
This study is all about helping researchers learn more about how chronic pain and substance use problems affect each other, so they can find better ways to help people who are struggling with both issues.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project start | August 12, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2024 |
| Award (this year) | $172,596 |
| NIH project number | 1T90NR021683-01 |
| Project ID | NIH-10935002 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals experiencing chronic pain who also have a history of substance use disorders.
✕Less likely to help
Patients who do not have chronic pain or substance use disorders may not benefit from this research.
What this research studies
This research focuses on the intersection of chronic pain and substance use disorders (SUD), aiming to enhance training for postdoctoral researchers in this critical area. It emphasizes understanding how social determinants of health impact pain and SUD outcomes, which can lead to better treatment options for affected patients. By developing skilled investigators, the program seeks to address significant gaps in knowledge and treatment for individuals dealing with both chronic pain and SUD.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for patients suffering from both chronic pain and substance use disorders.
How similar studies have gone: Other research has shown promise in addressing the dual challenges of pain and substance use disorders, indicating that this approach could lead to meaningful advancements.
Where this research is happening
-
Washington University
Saint Louis, United States Active
Researchers
- Principal investigator: Goodin, Burel R. — Washington University
- Study coordinator: Goodin, Burel R.
Related research
Other NIH-funded projects on the same topics.
-
Reducing Addiction Risk in High Schools Through Better Prevention Infrastructure
Aims to build a sustainable, school-based system to prevent opioid and other drug use among high school students, especially those at higher risk.
-
HEAL Data Platform to share addiction-related data across programs
A platform project to make HEAL data from many programs easier to find and use, helping researchers and clinicians access information about addiction in children and youth.
-
Cognitively-enhanced tDCS to reduce cocaine craving
A study to test whether real brain stimulation together with learning strategies can lessen craving in people with cocaine use disorder.
-
Yale center researching how tobacco products affect use and addiction in people
A Yale research center is studying how nicotine, flavor additives, and other ingredients in tobacco products influence people’s likelihood of starting and becoming addicted.
-
Atherosclerosis in cocaine addiction: imaging risk with PET/MR
This project uses PET/MR imaging to look for early artery disease in people with cocaine use disorder to help prevent strokes or other brain injuries.
-
Integrating long-acting PrEP into street medicine for people who use drugs
This project tests whether a long-acting HIV prevention shot (lenacapavir) can be feasibly and acceptably offered by street-based health teams to people who use drugs.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.